Latest Breaking News On - Matthias evers - Page 1 : vimarsana.com

Evotec SE (NASDAQ:EVO) Q1 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, welcome to the Evotec SE Quarterly Statement Q1 2024 Conference Call. I am Sandra, the chorus call operator.

United statesUnited kingdomEvotec biologicsFalko friedrichsJoseph heddenMario polywkaChristian ehmannMichael ryskinMatthias eversCraig johnstonPeter verdultMarcy lyonVolker braunBen jacksonThibault boutherinCharles weston

Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript

Evotec SE misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were $-0.03333.

United statesMario polywkaCharles westonChristian wojczewskiJacqueline kisaSteven mahMichael ryskinCraig johnstonMoritz nikolausPeter verdultMatthias eversEvotec biologicsVolker braunOur groupCountries that increased oil production the mostBiggest gold companies

Evotec SE: Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments

Evotec SE: Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Dennis riedlHinnerk rohwedderGabriele hansenMatthias eversAndrew farnumDavid mollerVolker braunVariant bio incHead of global corporate communicationsGlobal corporate communicationsEvotec se frankfurt stock exchangeFrankfurt stock exchangeVariant bioChief business officerGlobal investor relationsAktien sie

Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments

EQS-News: Evotec SE / Key word: Miscellaneous Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments 18.04.2024 / 13:27.

United statesAndrew farnumVolker braunDavid mollerMatthias eversGabriele hansenHinnerk rohwedderEvotec se frankfurt stock exchangeVariant bio incGlobal corporate communicationsHead of global corporate communicationsDistribution servicesVariant bioFrankfurt stock exchangeChief business officerGlobal investor relations

EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS

EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Matthias eversAndrew farnumVariant bio incPrnewswire evotec se frankfurt stock exchangeFrankfurt stock exchangeVariant bioChief business officer